• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    All News #Library
    Rare Diseases

    Soligenix Reports Interim Phase 3 FLASH2 HyBryte Results

    PR NEWSWIRE

    Clinical Results from HyBryte Comparative Study Against Valchlor

    PR NEWSWIRE

    Soligenix Receives Orphan Drug Designation for SGX945

    PR NEWSWIRE

    HyBryte Results Debut at 2026 US Cutaneous Lymphoma Workshop

    PR NEWSWIRE

    Soligenix Announces HyBryte Clinical Summary Published

    PR NEWSWIRE

    Soligenix Gains MHRA PIM Designation for SGX945

    PR NEWSWIRE

    Soligenix SGX945 Gets EMA Orphan Designation for Behçet`s Disease

    PR NEWSWIRE

    SGX945 Phase 2 Trial Shows Promising Results In Behçet`s Disease

    PR NEWSWIRE

    Soligenix Announces Top-line Results of the Ph 2a Study of SGX302

    PR NEWSWIRE

    Soligenix Advancing Rare-Disease Positioned at Pivotal Crossroad

    GLOBENEWSWIRE

    Breakthrough Therapies Rise as Rare Diseases Burden Aging

    GLOBENEWSWIRE

    Soligenix`s Innovative Platform Revolutionizes Treatment for CTCL

    GLOBENEWSWIRE

    HyBryte Targets Rare Diseases in Aging America

    GLOBENEWSWIRE

    Soligenix Reaches Enrollment Milestone In Phase 3 Trial

    PR NEWSWIRE

    Soligenix Reaches Safety Milestone In Phase 3 Trial Of Hybryte™

    PR NEWSWIRE

    FDA Designates Soligenix Drug Orphan Status for Behçet`s Disease

    PR NEWSWIRE

    Rare Disease Clinical Progress Boosts Long-Term Revenue Potential

    PR NEWSWIRE

    Ph 2 Trial Shows SGX945`s Efficacy in Treating Behçet`s Disease

    PR NEWSWIRE

    Soligenix Manufactures Synthetic Hypericin at Sterling Pharma

    PR NEWSWIRE

    Soligenix Launches Phase 2 Trial for SGX945 in Behçet`s Disease

    PR NEWSWIRE

    Soligenix, Inc. to Present at the 2024 ThinkEquity Conference

    GLOBENEWSWIRE

    Soligenix Announces Partnership with Sterling Pharma Solutions

    PR NEWSWIRE

    Soligenix extends patent protection for its Filovirus vaccine to UK&South Africa

    PHARMABIZ

    FDA Grants Soligenix Orphan Drug For Marburg Prevention, Prophylaxis

    PR NEWSWIRE

    Soligenix Granted FDA Orphan Drug Designation for SuVax Active Ingredient

    PR NEWSWIRE

    FDA Grants Soligenix Orphan Drug Designation for Treatment of T-cell Lymphoma

    BIOSPACE

    Soligenix Receives Hong Kong Patent for Therapeutic Use of Synthetic Hypericin

    PRNEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.